Clinical Trials

68 enrolled

Advanced Malignant Solid Neoplasm

NCT06367751 2026-03-11

LIQPLAT

159 enrolled

Advanced Solid Tumor

NCT07018622 2026-03-11

DAPA-ARMOR

Phase 2 Recruiting

46 enrolled

Solid Tumors

NCT06192875 2026-03-10

A Novel Molecular Approach to Blood DNA Screening for Cancer: Specificity Assessment (The NOMAD Study)

10,000 enrolled

Hematopoietic and Lymphoid System Neoplasm

NCT07450560 2026-03-10

Research on Real-time Proton Therapy Guidance Through Monitoring Proton Range Using All-digital PET

Active not recruiting

30 enrolled

Phase 2 Not yet recruiting

Solid Tumor

NCT07459920 2026-03-10

CAPTURE

156 enrolled

Phase 1/2 Active not recruiting

Advanced Malignant Solid Tumor

NCT07461181 2026-03-10

A Study to Evaluate the Safety, Tolerability, PK, PD, and Preliminary Efficacy of CS01 in Patients With Locally Advanced or Metastatic Solid Tumors

10 enrolled

Locally Advanced or Metastatic Solid Tumors

NCT04792463 2026-03-09

Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome

DermatologicGastrointestinalGenitourinaryOther solid neoplasmThoracic

500 enrolled

Uveal Melanoma, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Melanoma, Mesothelioma, Cholangiocarcinoma

NCT01761929 2026-03-06

5fr SBRT

Phase 2 Completed

138 enrolled

Phase 1 Active not recruiting

Solid Tumors With Oligometastatic Spread

NCT02959463 2026-03-06

Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma

24 enrolled 11 charts

Mesothelioma, Malignant

NCT05661201 2026-03-06

NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors

Phase 1 Recruiting

24 enrolled

Solid Tumor

NCT00797719 2026-03-05

Short Neoadjuvant Hemithoracic IMRT for MPM

Phase 1/2 Completed

104 enrolled

Mesothelioma, Malignant

NCT02701712 2026-03-05

MRgRT

150 enrolled

Solid Tumors and Metastatic Lesions

NCT04028570 2026-03-05

SMARTER

15 enrolled

Mesothelioma

NCT04928508 2026-03-05

Okgyn1

Phase 1 Recruiting

50 enrolled

Solid Tumor, Adult

NCT06279130 2026-03-05

NEOASIS

Phase 2/3 Recruiting

133 enrolled

Resectable MMR-deficient Solid Tumors

NCT03347318 2026-03-04

PROFILING

2,500 enrolled

Solid Tumors

NCT05436093 2026-03-04

CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors

15 enrolled

Solid Tumor

NCT07059884 2026-03-04

DEFEND

104 enrolled

Hematopoietic and Lymphatic System Neoplasm

NCT07449624 2026-03-04

From Presentation to Diagnosis: Patterns of Pleural Effusion

Completed

300 enrolled

Phase 2 Not yet recruiting

Mesothelioma, Malignant, Pleural Effusion

NCT07450352 2026-03-04

SEED-CRYO: Sequential 125I Seed Implantation Followed by Cryoablation vs Single-Modality Local Therapy in Unresectable Solid Tumors

150 enrolled

DermatologicGenitourinaryHead & NeckOther solid neoplasmSarcomaThoracic

Unresectable Solid Tumors

NCT03420963 2026-03-03

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

Phase 1 Terminated

12 enrolled

Mesothelioma, Malignant, Bone Neoplasms, Endocrine Gland Neoplasms, Melanoma, Mouth Neoplasms, Pharyngeal Neoplasms, Sarcoma, Skin Neoplasms, Thyroid Neoplasms, Urologic Neoplasms

NCT06304168 2026-03-03

Validation of DNA Methylation Markers for Universal and Site-specific Guided Cancer Detection, VANGUARD Study

6,150 enrolled

Hematopoietic and Lymphatic System Neoplasm

NCT07365007 2026-03-03

A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment

OtherOther solid neoplasm

50 enrolled

Chemotherapy-Induced Peripheral Neuropathy

NCT07446725 2026-03-03

A Study to Evaluate Safety, PK and Efficacy of GH55 in Combination With GH21 in Patients With Solid Tumors

Phase 1/2 Not yet recruiting

152 enrolled

Advanced Solid Tumor Cancer

NCT04425434 2026-03-02

GFARB12019

3,000 enrolled

Other neoplasmOther solid neoplasm

Retinoblastoma

NCT06612645 2026-03-02

CMD03

Phase 1 Recruiting

9 enrolled

Pediatric Cancers

NCT07443020 2026-03-02

RIOT 4B

Phase 1 Not yet recruiting

10 enrolled

Mesothelioma, Malignant, Pleural Effusion, Malignant

NCT06353191 2026-02-27

Biomarkers to Predict Cancer Therapy-related Cardiotoxicity

1,000 enrolled

Hematopoietic and Lymphatic System Neoplasm

NCT06945380 2026-02-27

Evaluating a Mobile Health Application Intervention for Caregiver Instruction in Manual Therapy for Chemotherapy-Induced Peripheral Neuropathy

OtherOther solid neoplasm

300 enrolled

Chemotherapy-Induced Peripheral Neuropathy

NCT07437625 2026-02-27

Lesion-Allocated Therapy for Multiple Metastases and Tumor-Zoned Treatment for Bulky Tumors: A Phase II Study of Iodine-125 Seed Implantation Combined With Cryoablation in High-Burden Metastatic Disease

Phase 2 Not yet recruiting

90 enrolled

Phase NA Not yet recruiting

High-Burden Metastatic Solid Tumors

NCT07438093 2026-02-27

Safety, Tolerability, and Preliminary Efficacy of Peginterferon α-2b in Combination With an Anti-PD-1 Antibody in Patients With Advanced or Metastatic Malignant Solid Tumors

60 enrolled

Phase EARLY_PHASE1 Recruiting

Advanced Solid Tumors

NCT05645523 2026-02-25

Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors

25 enrolled

Solid Tumor

NCT06484595 2026-02-25

GUIDE

Phase NA Completed

100 enrolled

Hematopoietic and Lymphatic System Neoplasm

NCT06409000 2026-02-24

Evaluation of 3D Surface Scanning for Virtual-CT Based Radiation Therapy Treatment Planning

Completed

26 enrolled

Hematopoietic and Lymphatic System Neoplasm

NCT07126496 2026-02-23

A Virtual Community Health Educator for Increasing Clinical Trial Referrals Among Cancer Patients and Their Caregivers

2,000 enrolled